Organon & Co. (OGN)
6.12
+0.07
(+1.16%)
USD |
NYSE |
Apr 07, 16:00
6.18
+0.06
(+0.98%)
After-Hours: 20:00
Organon Market Cap : 1.610B for April 7, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 291.17B |
| Corcept Therapeutics, Inc. | 4.528B |
| Plus Therapeutics, Inc. | 17.54M |
| Geron Corp. | 1.111B |
| Vertex Pharmaceuticals, Inc. | 109.06B |
Market Cap Related Metrics
| PE Ratio | 8.632 |
| PS Ratio | 0.2593 |
| Price to Book Value | 2.141 |
| Price to Free Cash Flow | 3.172 |
| Price | 6.12 |
| Earnings Yield | 11.58% |
| Operating PE Ratio | 1.295 |
| Normalized PE Ratio | 3.720 |